Auna (NYSE:AUNA) Downgraded to “Hold” Rating by Zacks Research

Auna (NYSE:AUNA) was downgraded by stock analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Tuesday,Zacks.com reports.

AUNA has been the subject of several other research reports. Jefferies Financial Group began coverage on Auna in a research report on Friday, January 16th. They issued a “buy” rating and a $9.00 price objective for the company. HSBC upgraded Auna from a “hold” rating to a “buy” rating and set a $6.90 target price for the company in a research note on Wednesday, January 21st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a report on Friday, March 27th. Finally, Wall Street Zen upgraded shares of Auna from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 28th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $7.30.

Auna Stock Performance

NYSE AUNA opened at $5.62 on Tuesday. Auna has a 1-year low of $4.46 and a 1-year high of $7.50. The company has a 50 day moving average of $5.19 and a 200-day moving average of $5.35. The company has a current ratio of 1.11, a quick ratio of 1.01 and a debt-to-equity ratio of 1.87. The firm has a market cap of $415.95 million, a price-to-earnings ratio of 15.61 and a beta of 2.09.

Auna (NYSE:AUNA) last announced its earnings results on Saturday, February 14th. The company reported $0.53 EPS for the quarter. The business had revenue of $596.55 million for the quarter. Auna had a return on equity of 19.23% and a net margin of 2.13%. On average, equities analysts forecast that Auna will post 0.5 earnings per share for the current fiscal year.

Institutional Trading of Auna

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AUNA. Goldman Sachs Group Inc. lifted its position in Auna by 43.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 71,645 shares of the company’s stock valued at $352,000 after purchasing an additional 21,579 shares during the period. Marshall Wace LLP grew its position in shares of Auna by 391.0% during the 4th quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock worth $802,000 after buying an additional 129,799 shares during the period. Citadel Advisors LLC grew its position in shares of Auna by 28.9% during the 3rd quarter. Citadel Advisors LLC now owns 36,352 shares of the company’s stock worth $244,000 after buying an additional 8,147 shares during the period. Heron Bay Capital Management bought a new stake in shares of Auna during the fourth quarter worth approximately $138,000. Finally, Millennium Management LLC raised its stake in shares of Auna by 115.2% during the fourth quarter. Millennium Management LLC now owns 26,475 shares of the company’s stock worth $130,000 after buying an additional 14,170 shares during the last quarter.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.